Promising Penny Stocks To Consider – October 13th

Alaunos Therapeutics, JBDI, and BIO-key International are the three Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are shares of small, often emerging companies that trade at very low prices, typically below $5 per share, although definitions can vary. They are generally more volatile and less liquid than larger-company stocks, making them higher-risk investments for stock market investors. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Alaunos Therapeutics (TCRT)

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers.

JBDI (JBDI)

JBDI Holdings Limited engages in the trading of reconditioned and recycling containers in Singapore and the Southeast Asia region. The company offers reconditioning and recycling drums, including open top drums, metal drums, plastic drums, plastic carboys, and intermediate bulk containers, as well as new drums, and collects waste drums and related products.

BIO-key International (BKYI)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.